NEULAND LABORATORIES
Back to Cashflow Statement
|
NEULAND LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹347 Cr | ₹317 Cr | ₹261 Cr | ₹237 Cr | ₹60 Cr |
What is the latest Cash Flow from Operating Activities ratio of NEULAND LABORATORIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹347 Cr |
| Mar2025 | ₹317 Cr |
| Mar2024 | ₹261 Cr |
| Mar2023 | ₹237 Cr |
| Mar2022 | ₹60 Cr |
How is Cash Flow from Operating Activities of NEULAND LABORATORIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹347 Cr | 9.22 | |
| Mar2025 | ₹317 Cr | 21.53 | |
| Mar2024 | ₹261 Cr | 10.10 | |
| Mar2023 | ₹237 Cr | 292.81 | |
| Mar2022 | ₹60 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹24,182.0 Cr | -1% | 8.9% | 29.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,786.0 Cr | 0.5% | 6.8% | 16.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,590.0 Cr | 0.6% | 8.7% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,658.0 Cr | 0.4% | 13.8% | 46.9% | Stock Analytics | |
| CIPLA | ₹115,728.0 Cr | -0.4% | 5.8% | -2.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,708.0 Cr | -1.9% | -5.1% | -2.2% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -1% |
8.9% |
29.7% |
| SENSEX | 0.5% |
0.1% |
-6.1% |
You may also like the below Video Courses